Literature DB >> 9703360

Cell cycle-dependent modulation of promoter activities of RB and WAF1/Cip1 genes.

T Matsumoto1, N Ohtani-Fujita, Y Sowa, F Bai, T Nikaido, T Tamaki, T Sakai.   

Abstract

A universal inhibitor of cyclin-dependent kinases, WAF1/Cip1 can dephosphorylate the RB gene product to arrest the cell cycle at the G1 phase. Here we show that the mRNA level and the promoter activities of the RB and WAF1/Cip1 genes exhibit cell cycle-dependent change when cells are released from either serum-starvation or the confluent cell state with serum. RB expression and promoter activity are elevated at middle to late G1. In contrast, the mRNA and promoter activity of the WAF1/Cip1 gene increase at early G1. These results suggest that the RB and WAF1/Cip1 expression and promoter activities depend not only on serum, but also on the cell cycle progression itself. Moreover, we identified the responsive region for serum-released cell cycle progression in the RB promoter and mapped it to the region between -4 and -182 relative to the initiating codon of the RB gene. The region in the WAF1/Cip1 promoter responsible for the serum-released cell cycle progression mapped not to the p53 binding site, but to the 374 base-pair region between -1770 and -1396 from the transcription start site.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9703360      PMCID: PMC5921868          DOI: 10.1111/j.1349-7006.1998.tb03264.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  37 in total

1.  The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle.

Authors:  D W Goodrich; N P Wang; Y W Qian; E Y Lee; W H Lee
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

2.  N-myc suppression and cell cycle arrest at G1 phase by prostaglandins.

Authors:  N Marui; T Sakai; N Hosokawa; M Yoshida; A Aoike; K Kawai; H Nishino; M Fukushima
Journal:  FEBS Lett       Date:  1990-09-17       Impact factor: 4.124

3.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

4.  Effect of tumor suppressors on cell cycle-regulatory genes: RB suppresses p34cdc2 expression and normal p53 suppresses cyclin A expression.

Authors:  M Yamamoto; M Yoshida; K Ono; T Fujita; N Ohtani-Fujita; T Sakai; T Nikaido
Journal:  Exp Cell Res       Date:  1994-01       Impact factor: 3.905

5.  Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation.

Authors:  P L Chen; P Scully; J Y Shew; J Y Wang; W H Lee
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

6.  Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta.

Authors:  R Chinery; J A Brockman; M O Peeler; Y Shyr; R D Beauchamp; R J Coffey
Journal:  Nat Med       Date:  1997-11       Impact factor: 53.440

7.  Structure and cell cycle-regulated transcription of the human cyclin A gene.

Authors:  B Henglein; X Chenivesse; J Wang; D Eick; C Bréchot
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

8.  Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene.

Authors:  T Sakai; N Ohtani; T L McGee; P D Robbins; T P Dryja
Journal:  Nature       Date:  1991-09-05       Impact factor: 49.962

9.  Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.

Authors:  Y E Chin; M Kitagawa; W C Su; Z H You; Y Iwamoto; X Y Fu
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

10.  Inactivation of p53 gene in human and murine osteosarcoma cells.

Authors:  N Chandar; B Billig; J McMaster; J Novak
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

View more
  1 in total

1.  Regulation of RB transcription in vivo by RB family members.

Authors:  Deborah L Burkhart; Lynn K Ngai; Caitlin M Roake; Patrick Viatour; Chellappagounder Thangavel; Victoria M Ho; Erik S Knudsen; Julien Sage
Journal:  Mol Cell Biol       Date:  2010-01-25       Impact factor: 4.272

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.